Showing 1 - 1 results of 1 for search 'David H. Wagner', query time: 0.01s Refine Results
  1. 1
    Slow Subcutaneous Release of Glatiramer Acetate or CD40-Targeting Peptide KGYY<sub>6</sub> Is More Advantageous in Treating Ongoing Experimental Autoimmune Encephalomyelitis

    Slow Subcutaneous Release of Glatiramer Acetate or CD40-Targeting Peptide KGYY<sub>6</sub> Is More Advantageous in Treating Ongoing Experimental Autoimmune Encephalomyelitis by Gisela M. Vaitaitis, David H. Wagner

    Published 2024-11-01
    Get full text
    Article
    Save to List
    Saved in:

Search Tools: